Core Insights - The iShares U.S. Pharmaceuticals ETF (IHE) is currently trading at a forward earnings multiple of 15.69x and is projected to see an earnings per share growth of 19.07% over the next twelve months according to analysts [1] Group 1: ETF Overview - The iShares U.S. Pharmaceuticals ETF (IHE) focuses on the pharmaceutical sector within the U.S. equity market [1] - The ETF is analyzed using a proprietary ranking system that evaluates nearly 1,000 ETFs based on various factors including costs, liquidity, risk, size, value, dividends, growth, quality, momentum, and sentiment [1] Group 2: Analyst Background - The Sunday Investor, who covers U.S. Equity ETFs, has a strong analytical background and holds a Certificate of Advanced Investment Advice from the Canadian Securities Institute [1] - The Sunday Investor has completed all educational requirements for the Chartered Investment Manager designation [1]
IHE: U.S. Pharmaceuticals ETF With Excellent GARP Features
Seeking Alpha·2026-02-27 21:18